melatonin has been researched along with Fatty Liver in 28 studies
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate, in the liver of adult offspring, the possible effects of melatonin supplementation in the obese mother during pregnancy and lactation." | 8.31 | Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress. ( Aguila, MB; Ajackson, M; Mandarim-de-Lacerda, CA; Marcondes-de-Castro, IA; Nagagata, BA, 2023) |
| "Non-alcoholic fatty liver disease (NAFLD), most common chronic hepatic pathology, that occurs in the developed countries is estimated at 1/3 of the population." | 6.79 | Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up. ( Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Korolczuk, A; Slomka, M, 2014) |
| "Melatonin (MT) plays a crucial role in the regulation of inflammatory response." | 5.91 | Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis. ( Miao, Z; Teng, X; Xu, S, 2023) |
| "Melatonin plays an important role in regulating circadian rhythms." | 5.48 | Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha-2-HS-glycoprotein. ( Baik, SH; Choi, DS; Choi, KM; Heo, JI; Kim, NH; Kim, SG; Seo, JA; Yoo, HJ; Yoon, DW; Yu, JH, 2018) |
| "Excess weight and obesity are severe public health threats worldwide." | 5.46 | Melatonin prevents obesity through modulation of gut microbiota in mice. ( Hong, F; Jia, L; Jin, X; Wang, J; Wang, S; Xu, P; Xue, T; Zhai, Y, 2017) |
| " Thus, the antihyperlipemic effect of melatonin, which was first discovered in hypercholesterolemia produced by short- or long-term administration of glucocorticoids, has now been proved to be rather universal and not simply anti-glucocorticoidal." | 5.27 | Effects of melatonin on genetic hypercholesterolemia in rats. ( Aoyama, H; Mori, N; Mori, W, 1988) |
| "To investigate, in the liver of adult offspring, the possible effects of melatonin supplementation in the obese mother during pregnancy and lactation." | 4.31 | Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress. ( Aguila, MB; Ajackson, M; Mandarim-de-Lacerda, CA; Marcondes-de-Castro, IA; Nagagata, BA, 2023) |
| " The altered proteins are related to the development of liver pathology, such as cirrhosis (α1-antiproteinase), thrombosis (fibrinogen, plasminogen), and inflammation (mannose-binding protein A, complement C4, complement factor B), contributing to liver steatosis or hepatic cell death." | 3.85 | High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation. ( Govitrapong, P; Isarankura-Na-Ayudhya, C; Kitidee, K; Klosen, P; Pannengpetch, S; Wongchitrat, P, 2017) |
| "Non-alcoholic fatty liver disease (NAFLD), most common chronic hepatic pathology, that occurs in the developed countries is estimated at 1/3 of the population." | 2.79 | Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up. ( Brzozowski, T; Celinski, K; Cichoz-Lach, H; Konturek, PC; Konturek, SJ; Korolczuk, A; Slomka, M, 2014) |
| "Melatonin is a powerful endogenous antioxidant produced by the pineal gland and a variety of other because of its efficacy in organs; melatonin has been investigated to improve the outcome of organ transplantation by reducing ischemia-reperfusion injury and due to its synergic effect with organ preservation fluids." | 2.53 | Melatonin role preventing steatohepatitis and improving liver transplantation results. ( Alatorre-Jiménez, MA; Esteban-Zubero, E; García, JJ; García-Gil, FA; López-Pingarrón, L; Ramírez, JM; Reiter, RJ; Tan, DX, 2016) |
| "Melatonin is a remarkable molecule with diverse biological and physiological actions and is involved in the regulation of various important functions such as circadian rhythm, energy metabolism, the reproductive system, the cardiovascular system, and the neuropsychiatric system." | 2.52 | Melatonin: a potential intervention for hepatic steatosis. ( Huang, FF; Qu, S; Sun, H, 2015) |
| "Melatonin (MT) plays a crucial role in the regulation of inflammatory response." | 1.91 | Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis. ( Miao, Z; Teng, X; Xu, S, 2023) |
| "Melatonin plays an important role in regulating circadian rhythms." | 1.48 | Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha-2-HS-glycoprotein. ( Baik, SH; Choi, DS; Choi, KM; Heo, JI; Kim, NH; Kim, SG; Seo, JA; Yoo, HJ; Yoon, DW; Yu, JH, 2018) |
| "Excess weight and obesity are severe public health threats worldwide." | 1.46 | Melatonin prevents obesity through modulation of gut microbiota in mice. ( Hong, F; Jia, L; Jin, X; Wang, J; Wang, S; Xu, P; Xue, T; Zhai, Y, 2017) |
| "Melatonin has been shown to protect cells against oxidative and inflammatory damage via endocrine, paracrine and autocrine actions." | 1.43 | Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency. ( Constantin, J; Gilglioni, EH; Hermoso, APM; Hermoso, DAM; Iwamoto, ELI; Mito, MS; Salgueiro-Pagadigorria, CL; Shimada, LBC, 2016) |
| "In addition, this treatment improved fatty liver, decreased hepatic triglyceride concentration and increased apolipoprotein B100 in liver tissue." | 1.37 | Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice. ( Fernández-Moreira, D; García Ruiz, I; García-Consuegra, I; Gómez-Izquierdo, E; Muñoz-Yagüe, T; Solís-Herruzo, JA; Solís-Muñoz, P, 2011) |
| "The mechanism by which nonalcoholic fatty liver disease (NAFLD) progresses into nonalcoholic steatohepatitis (NASH) is unknown, however, the major process is oxidative stress with increased production of reactive oxygen species and excessive inflammatory cytokine generation." | 1.36 | The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin. ( Bielanski, W; Brzozowski, T; Gonciarz, M; Gonciarz, Z; Konturek, PC; Konturek, SJ; Mularczyk, A, 2010) |
| "Nonalcoholic steatohepatitis (NASH) may progress to advanced fibrosis and cirrhosis." | 1.35 | Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats. ( Akin, H; Atug, O; Avsar, E; Celikel, C; Eren, F; Imeryuz, N; Ozdogan, O; Ozguner, F; Tahan, G; Tahan, V; Tarcin, O; Tozun, N; Uzun, H, 2009) |
| " Thus, the antihyperlipemic effect of melatonin, which was first discovered in hypercholesterolemia produced by short- or long-term administration of glucocorticoids, has now been proved to be rather universal and not simply anti-glucocorticoidal." | 1.27 | Effects of melatonin on genetic hypercholesterolemia in rats. ( Aoyama, H; Mori, N; Mori, W, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 20 (71.43) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, N | 1 |
| Nieto, MA | 1 |
| Suarez-Zamora, DA | 1 |
| Moreno, S | 1 |
| Remolina, CI | 1 |
| Durán, D | 1 |
| Vega, D | 1 |
| Rodríguez-Urrego, PA | 1 |
| Gómez, CP | 1 |
| Rojas, DP | 1 |
| Ramírez, A | 1 |
| Martínez, O | 1 |
| Baldión-Elorza, AM | 1 |
| Hernández, LJ | 1 |
| Quintero, J | 1 |
| Budhiraja, S | 1 |
| Tarai, B | 1 |
| Jain, D | 1 |
| Aggarwal, M | 2 |
| Indrayan, A | 1 |
| Das, P | 1 |
| Mishra, RS | 1 |
| Bali, S | 1 |
| Mahajan, M | 1 |
| Kirtani, J | 1 |
| Tickoo, R | 1 |
| Soni, P | 1 |
| Nangia, V | 1 |
| Lall, A | 1 |
| Kishore, N | 1 |
| Jain, A | 1 |
| Singh, O | 1 |
| Singh, N | 1 |
| Kumar, A | 1 |
| Saxena, P | 1 |
| Dewan, A | 1 |
| Aggarwal, R | 1 |
| Mehra, M | 1 |
| Jain, M | 1 |
| Nakra, V | 1 |
| Sharma, BD | 1 |
| Pandey, PK | 1 |
| Singh, YP | 1 |
| Arora, V | 2 |
| Jain, S | 2 |
| Chhabra, R | 1 |
| Tuli, P | 1 |
| Boobna, V | 1 |
| Joshi, A | 1 |
| Gupta, R | 1 |
| Aneja, P | 1 |
| Dhall, S | 1 |
| Chugh, IM | 1 |
| Garg, S | 1 |
| Mittal, V | 1 |
| Gupta, A | 3 |
| Jyoti, B | 1 |
| Sharma, P | 1 |
| Bhasin, P | 1 |
| Singhal, RK | 1 |
| Bhasin, A | 1 |
| Vardani, A | 1 |
| Pal, V | 1 |
| Pande, DG | 1 |
| Gulati, T | 1 |
| Nayar, S | 1 |
| Kalra, S | 1 |
| Garg, M | 1 |
| Pande, R | 1 |
| Bag, P | 1 |
| Sharma, J | 1 |
| Handoo, A | 1 |
| Burman, P | 1 |
| Gupta, AK | 1 |
| Choudhary, PN | 1 |
| Gupta, P | 2 |
| Joshi, S | 1 |
| Tayal, N | 1 |
| Gupta, M | 1 |
| Khanna, A | 1 |
| Kishore, S | 1 |
| Sahay, S | 1 |
| Dang, R | 1 |
| Mishra, N | 1 |
| Sekhri, S | 1 |
| Srivastava, RC | 1 |
| Agrawal, MB | 1 |
| Mathur, M | 1 |
| Banwari, A | 1 |
| Khetarpal, S | 1 |
| Pandove, S | 1 |
| Bhasin, D | 1 |
| Singh, H | 1 |
| Midha, D | 1 |
| Bhutani, A | 1 |
| Kaur, M | 1 |
| Singh, A | 1 |
| Sharma, S | 1 |
| Singla, K | 1 |
| Sagar, V | 1 |
| Dixit, A | 1 |
| Bajpai, R | 1 |
| Chachra, V | 1 |
| Tyagi, P | 1 |
| Saxena, S | 1 |
| Uniyal, B | 1 |
| Belwal, S | 1 |
| Aier, I | 1 |
| Singhal, M | 1 |
| Khaduri, A | 1 |
| Du, Z | 1 |
| Liang, S | 1 |
| Li, Y | 1 |
| Zhang, J | 1 |
| Yu, Y | 1 |
| Xu, Q | 1 |
| Sun, Z | 1 |
| Duan, J | 1 |
| Cao, N | 1 |
| Hu, C | 1 |
| Xia, B | 1 |
| He, Y | 1 |
| Huang, J | 1 |
| Yuan, Z | 1 |
| Deng, J | 1 |
| Duan, P | 1 |
| Liu, Q | 1 |
| Guo, S | 1 |
| Huang, Y | 1 |
| Wei, X | 1 |
| Liu, L | 1 |
| Huo, F | 1 |
| Huang, P | 1 |
| Wu, Y | 1 |
| Tian, W | 1 |
| Miao, Z | 6 |
| Teng, X | 3 |
| Xu, S | 3 |
| Ajackson, M | 2 |
| Nagagata, BA | 2 |
| Marcondes-de-Castro, IA | 2 |
| Mandarim-de-Lacerda, CA | 2 |
| Aguila, MB | 2 |
| Veronesi, VB | 1 |
| Pioli, MR | 1 |
| de Souza, DN | 1 |
| Teixeira, CJ | 1 |
| Murata, GM | 1 |
| Santos-Silva, JC | 1 |
| Hecht, FB | 1 |
| Vicente, JM | 1 |
| Bordin, S | 1 |
| Anhê, GF | 1 |
| Wongchitrat, P | 1 |
| Klosen, P | 1 |
| Pannengpetch, S | 1 |
| Kitidee, K | 1 |
| Govitrapong, P | 1 |
| Isarankura-Na-Ayudhya, C | 1 |
| Báez-Ruiz, A | 1 |
| Guerrero-Vargas, NN | 1 |
| Cázarez-Márquez, F | 1 |
| Sabath, E | 1 |
| Basualdo, MDC | 1 |
| Salgado-Delgado, R | 1 |
| Escobar, C | 1 |
| Buijs, RM | 1 |
| Heo, JI | 1 |
| Yoon, DW | 1 |
| Yu, JH | 1 |
| Kim, NH | 2 |
| Yoo, HJ | 1 |
| Seo, JA | 1 |
| Kim, SG | 1 |
| Choi, KM | 1 |
| Baik, SH | 1 |
| Choi, DS | 1 |
| Rong, B | 1 |
| Feng, R | 1 |
| Liu, C | 1 |
| Wu, Q | 1 |
| Sun, C | 1 |
| Zaouali, MA | 2 |
| Boncompagni, E | 2 |
| Reiter, RJ | 4 |
| Bejaoui, M | 1 |
| Freitas, I | 2 |
| Pantazi, E | 1 |
| Folch-Puy, E | 1 |
| Abdennebi, HB | 1 |
| Garcia-Gil, FA | 3 |
| Roselló-Catafau, J | 2 |
| Talu, MF | 1 |
| Gül, M | 1 |
| Alpaslan, N | 1 |
| Yiğitcan, B | 1 |
| Celinski, K | 3 |
| Konturek, PC | 5 |
| Slomka, M | 2 |
| Cichoz-Lach, H | 2 |
| Brzozowski, T | 4 |
| Konturek, SJ | 5 |
| Korolczuk, A | 1 |
| Tiao, MM | 1 |
| Huang, LT | 1 |
| Chen, CJ | 1 |
| Sheen, JM | 1 |
| Tain, YL | 1 |
| Chen, CC | 1 |
| Kuo, HC | 1 |
| Huang, YH | 1 |
| Tang, KS | 1 |
| Chu, EW | 1 |
| Yu, HR | 1 |
| Kim, SJ | 1 |
| Kang, HS | 1 |
| Lee, JH | 1 |
| Park, JH | 1 |
| Jung, CH | 1 |
| Bae, JH | 1 |
| Oh, BC | 1 |
| Song, DK | 1 |
| Baek, WK | 1 |
| Im, SS | 1 |
| Sun, H | 1 |
| Huang, FF | 1 |
| Qu, S | 1 |
| Esteban-Zubero, E | 1 |
| López-Pingarrón, L | 1 |
| Alatorre-Jiménez, MA | 1 |
| Ramírez, JM | 1 |
| Tan, DX | 1 |
| García, JJ | 2 |
| Hermoso, DAM | 1 |
| Shimada, LBC | 1 |
| Gilglioni, EH | 1 |
| Constantin, J | 1 |
| Mito, MS | 1 |
| Hermoso, APM | 1 |
| Salgueiro-Pagadigorria, CL | 1 |
| Iwamoto, ELI | 1 |
| Xu, P | 1 |
| Wang, J | 1 |
| Hong, F | 1 |
| Wang, S | 1 |
| Jin, X | 1 |
| Xue, T | 1 |
| Jia, L | 1 |
| Zhai, Y | 1 |
| Tahan, V | 1 |
| Atug, O | 1 |
| Akin, H | 1 |
| Eren, F | 1 |
| Tahan, G | 1 |
| Tarcin, O | 2 |
| Uzun, H | 1 |
| Ozdogan, O | 1 |
| Imeryuz, N | 1 |
| Ozguner, F | 1 |
| Celikel, C | 1 |
| Avsar, E | 1 |
| Tozun, N | 1 |
| Shieh, JM | 1 |
| Wu, HT | 1 |
| Cheng, KC | 1 |
| Cheng, JT | 1 |
| Padrissa-Altés, S | 1 |
| Ben Abnennebi, H | 1 |
| Gonciarz, M | 3 |
| Gonciarz, Z | 2 |
| Bielanski, W | 3 |
| Mularczyk, A | 2 |
| Solís-Muñoz, P | 1 |
| Solís-Herruzo, JA | 1 |
| Fernández-Moreira, D | 1 |
| Gómez-Izquierdo, E | 1 |
| García-Consuegra, I | 1 |
| Muñoz-Yagüe, T | 1 |
| García Ruiz, I | 1 |
| Zaitone, S | 1 |
| Hassan, N | 1 |
| El-Orabi, N | 1 |
| El-Awady, el-S | 1 |
| Partyka, R | 1 |
| Eszyk, J | 1 |
| Pan, M | 1 |
| Song, YL | 1 |
| Xu, JM | 1 |
| Gan, HZ | 1 |
| Aoyama, H | 1 |
| Mori, N | 1 |
| Mori, W | 1 |
2 reviews available for melatonin and Fatty Liver
| Article | Year |
|---|---|
Melatonin: a potential intervention for hepatic steatosis.
Topics: Adiposity; Animals; Antioxidants; Fatty Liver; Humans; Insulin Resistance; Lipid Metabolism; Melaton | 2015 |
Melatonin role preventing steatohepatitis and improving liver transplantation results.
Topics: Animals; Antioxidants; Fatty Liver; Humans; Liver; Liver Transplantation; Melatonin; Oxidative Stres | 2016 |
4 trials available for melatonin and Fatty Liver
| Article | Year |
|---|---|
Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up.
Topics: Adult; Cholesterol, LDL; Cytokines; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Lipid Me | 2014 |
The effects of L-tryptophan and melatonin on selected biochemical parameters in patients with steatohepatitis.
Topics: Adult; Antioxidants; Cytokines; Fatty Liver; Female; gamma-Glutamyltransferase; Hepatocytes; Humans; | 2010 |
The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: a pilot study.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Blood Glucose; Chole | 2012 |
Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin.
Topics: Adiponectin; Adult; Fatty Liver; Female; Ghrelin; Humans; Insulin; Leptin; Male; Melatonin; Resistin | 2013 |
22 other studies available for melatonin and Fatty Liver
| Article | Year |
|---|---|
Topics: AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Apoptosis; Asthenozoospermia; Calcium; eI | 2022 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Melatonin alleviates lead-induced fatty liver in the common carps (Cyprinus carpio) via gut-liver axis.
Topics: Animals; Carps; Fatty Liver; Lead; Lipopolysaccharides; Liver; Melatonin | 2023 |
Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Dietary Supplements; Endoplasmic Reticulum S | 2023 |
Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Dietary Supplements; Endoplasmic Reticulum S | 2023 |
Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Dietary Supplements; Endoplasmic Reticulum S | 2023 |
Adult mice offspring of obese mothers supplemented with melatonin show lessened liver steatosis, inflammation, oxidative stress, and endoplasmic reticulum stress.
Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Dietary Supplements; Endoplasmic Reticulum S | 2023 |
Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats.
Topics: Acetamides; Animals; Apolipoproteins B; Body Weight; Carrier Proteins; Energy Intake; Fatty Liver; F | 2021 |
High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation.
Topics: alpha 1-Antitrypsin; Animals; Biomarkers; Blood Glucose; Blood Proteins; Body Weight; Complement C4; | 2017 |
Food in synchrony with melatonin and corticosterone relieves constant light disturbed metabolism.
Topics: Adiposity; Animals; Chronobiology Disorders; Corticosterone; Fatty Liver; Feeding Methods; Glucose M | 2017 |
Melatonin improves insulin resistance and hepatic steatosis through attenuation of alpha-2-HS-glycoprotein.
Topics: alpha-2-HS-Glycoprotein; Animals; Dietary Fats; Endoplasmic Reticulum Stress; Fatty Liver; Hep G2 Ce | 2018 |
Reduced delivery of epididymal adipocyte-derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice.
Topics: Adipocytes; Animals; Exosomes; Fatty Liver; Male; Melatonin; Mice; Mice, Inbred C57BL; Random Alloca | 2019 |
AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Endoplasmic Reticulum Stress; Fatty Liver; Histoc | 2013 |
Calculation of melatonin and resveratrol effects on steatosis hepatis using soft computing methods.
Topics: Algorithms; Animals; Computer Systems; Fatty Liver; Humans; Image Processing, Computer-Assisted; Liv | 2013 |
Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure.
Topics: Animals; Apoptosis; Cytokines; Fatty Liver; Female; Glucocorticoids; Liver; Male; Melatonin; Pregnan | 2014 |
Melatonin ameliorates ER stress-mediated hepatic steatosis through miR-23a in the liver.
Topics: Animals; Antioxidants; Cell Line; Cells, Cultured; Endoplasmic Reticulum Stress; Fatty Liver; Gene E | 2015 |
Melatonin protects female rats against steatosis and liver oxidative stress induced by oestrogen deficiency.
Topics: Animals; Estrogens; Fatty Acids; Fatty Liver; Female; Lipids; Liver; Melatonin; Mitochondria, Liver; | 2016 |
Melatonin prevents obesity through modulation of gut microbiota in mice.
Topics: Animals; Bacteroidetes; Blotting, Western; Central Nervous System Depressants; Diet, High-Fat; Fatty | 2017 |
Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats.
Topics: Animals; Apoptosis; Biomarkers; Choline; Choline Deficiency; Cytokines; Diet; Fatty Liver; Glutathio | 2009 |
Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-GSK3beta pathway in hepatic cells.
Topics: Animals; Antioxidants; Blotting, Western; Cell Line, Tumor; Diabetes Mellitus, Experimental; Dietary | 2009 |
Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
Topics: Animals; Fatty Liver; Liver; Male; Melatonin; Nitric Oxide; Oxidative Stress; Rats; Rats, Zucker; Re | 2011 |
The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
Topics: Alanine Transaminase; Antioxidants; Aspartate Aminotransferases; Blood Glucose; Cholesterol; Fatty L | 2010 |
Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice.
Topics: Animals; Blotting, Western; Body Weight; Electron Transport Chain Complex Proteins; Fatty Liver; His | 2011 |
Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Body Weight; C | 2011 |
Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
Topics: Animals; Dietary Fats; Fatty Liver; Glutathione Peroxidase; Lipid Peroxidation; Liver; Male; Malondi | 2006 |
Effects of melatonin on genetic hypercholesterolemia in rats.
Topics: Animals; Cholesterol; Fatty Liver; Hypercholesterolemia; Hypolipidemic Agents; Kidney; Liver; Male; | 1988 |